Search Results - "Barca, Eva Gonzalez"

Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study by Salles, Gilles, Duell, Johannes, González Barca, Eva, Tournilhac, Olivier, Jurczak, Wojciech, Liberati, Anna Marina, Nagy, Zsolt, Obr, Aleš, Gaidano, Gianluca, André, Marc, Kalakonda, Nagesh, Dreyling, Martin, Weirather, Johannes, Dirnberger-Hertweck, Maren, Ambarkhane, Sumeet, Fingerle-Rowson, Günter, Maddocks, Kami

“…Patients with relapsed or refractory diffuse large B-cell lymphoma who are ineligible for autologous stem-cell transplantation have poor outcomes and few…”
Get full text

Role of Bispecific Antibodies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma in the CART Era by González Barca, Eva

“…Diffuse large B-cell lymphoma is an aggressive and biologically heterogeneous disease. R-CHOP is the standard first line therapy and cures more than 60% of…”
Get full text

Developing New Strategies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma by Gonzalez Barca, Eva

“…Diffuse large B-cell lymphoma (DLBCL) is an aggressive and biologically heterogeneous disease. Approximately 40% of patients with DLBCL will experience disease…”
Get full text

MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy by Valera, Alexandra, López-Guillermo, Armando, Cardesa-Salzmann, Teresa, Climent, Fina, González-Barca, Eva, Mercadal, Santiago, Espinosa, Iñigo, Novelli, Silvana, Briones, Javier, Mate, José L, Salamero, Olga, Sancho, Juan M, Arenillas, Leonor, Serrano, Sergi, Erill, Nadina, Martínez, Daniel, Castillo, Paola, Rovira, Jordina, Martínez, Antonio, Campo, Elias, Colomo, Luis

“…MYC alterations influence the survival of patients with diffuse large B-cell lymphoma. Most studies have focused on MYC translocations but there is little…”
Get full text

The BCL-2 family members NOXA and BIM mediate fluorizoline-induced apoptosis in multiple myeloma cells by Cosialls, Ana M., Sánchez-Vera, Ismael, Pomares, Helena, Perramon-Andújar, Judit, Sanchez-Esteban, Sandra, Palmeri, Claudia M., Iglesias-Serret, Daniel, Saura-Esteller, José, Núñez-Vázquez, Sonia, Lavilla, Rodolfo, González-Barca, Eva M., Pons, Gabriel, Gil, Joan

“…[Display omitted] Fluorizoline is a new synthetic molecule that induces apoptosis by selectively targeting prohibitins. In this study, we have assessed the…”
Get full text

The prohibitin-binding compound fluorizoline induces apoptosis in chronic lymphocytic leukemia cells through the upregulation of NOXA and synergizes with ibrutinib, 5-aminoimidazole-4-carboxamide riboside or venetoclax by Cosialls, Ana M, Pomares, Helena, Iglesias-Serret, Daniel, Saura-Esteller, José, Núñez-Vázquez, Sonia, González-Gironès, Diana M, de la Banda, Esmeralda, Preciado, Sara, Albericio, Fernando, Lavilla, Rodolfo, Pons, Gabriel, González-Barca, Eva M, Gil, Joan

“…Fluorizoline is a new synthetic molecule that induces apoptosis by selectively targeting prohibitins. In the study herein, the pro-apoptotic effect of…”
Get full text

In vitro and in vivo activity of a new small-molecule inhibitor of HDAC6 in mantle cell lymphoma by Pérez-Salvia, Montserrat, Aldaba, Eneko, Vara, Yosu, Fabre, Myriam, Ferrer, Cristina, Masdeu, Carme, Zubia, Aizpea, Sebastian, Eider San, Otaegui, Dorleta, Llinàs-Arias, Pere, Rosselló-Tortella, Margalida, Berdasco, Maria, Moutinho, Catia, Setien, Fernando, Villanueva, Alberto, González-Barca, Eva, Muncunill, Josep, Navarro, José-Tomás, Piris, Miguel A, Cossio, Fernando P, Esteller, Manel

“…Cancer origin and development is associated not only with genetic alterations, but also with the disturbance of epigenetic profiles.1 In this regard, the…”
Get full text

Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL): real-life experience with long-term outcomes, toxicities and responses to second-line therapies by Oliveira, Ana C., Roncero, Josep Maria, Ferrá, Christelle, Do Nascimento, Janilson, Rodriguez-Luaces, Marta, Encuentra, Maite, Domingo-Domenech, Eva, López, Patricia, Gallardo, David, Ribera, Josep Maria, Sarrá, Josep, Sureda, Anna, González-Barca, Eva

“…Fludarabine-cyclophosphamide-rituximab (FCR) has been the gold standard front-line treatment for fit CLL patients until novel agent’s introduction. Decision…”
Get full text

Identification of Leptomeningeal Disease in Aggressive B-Cell Non-Hodgkin's Lymphoma: Improved Sensitivity of Flow Cytometry by QUIJANO, Sandra, LOPEZ, Antonio, PENALVER, Francisco Javier, PLAZA-VILLA, Josefa, MORADO, Marta, GARCIA-MARCO, José, ARIAS, Jesus, BRIONES, Javier, FERRER, Secundino, CAPOTE, Javier, NICOLAS, Concepcion, ORFAO, Alberto, SANCHO, Juan Manuel, PANIZO, Carlos, DEBEN, Guillermo, CASTILLA, Cristina, GARCIA-VELA, José Antonio, SALAR, Antonio, ALONSO-VENCE, Natalia, GONZALEZ-BARCA, Eva

“…Here, we evaluate the sensitivity and specificity of a new 11-parameter flow cytometry (FCM) approach versus conventional cytology (CC) for detecting…”
Get full text

A new prognostic model identifies patients aged 80 years and older with diffuse large B‐cell lymphoma who may benefit from curative treatment: A multicenter, retrospective analysis by the Spanish GELTAMO group by Pardal, Emilia, Díez Baeza, Eva, Salas, Queralt, García, Tomás, Sancho, Juan M., Monzón, Encarna, Moraleda, José M., Córdoba, Raúl, de la Cruz, Fátima, Queizán, José A., Rodríguez, María J., Navarro, Belén, Hernández, José A., Díez, Rosana, Vahi, María, Viguria, María C., Canales, Miguel, Peñarrubia, María J., González‐López, Tomás J., Montes‐Moreno, Santiago, González‐Barca, Eva, Caballero, Dolores, Martín, Alejandro

“…The means of optimally managing very elderly patients with diffuse large B‐cell lymphoma (DLBCL) has not been established. We retrospectively analyzed 252…”
Get full text

Intensification treatment based on early FDG‐PET in patients with high‐risk diffuse large B‐cell lymphoma: a phase II GELTAMO trial by Pardal, Emilia, Coronado, Mónica, Martín, Alejandro, Grande, Carlos, Marín‐Niebla, Ana, Panizo, Carlos, Bello, José Luis, Conde, Eulogio, Hernández, Miguel T., Arranz, Reyes, Bargay, Joan, González‐Barca, Eva, Pérez‐Ceballos, Elena, Montes‐Moreno, Santiago, Caballero, María Dolores

“…Summary We conducted a multicentre, phase II study of interim positron emission tomography (PET) as a guide to risk‐adapted therapy in high‐risk patients with…”
Get full text

European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma by Zinzani, Pier Luigi, Karlin, Lionel, Radford, John, Caballero, Dolores, Fields, Paul, Chamuleau, Martine E D, d'Amore, Francesco, Haioun, Corinne, Thieblemont, Catherine, González-Barca, Eva, García, Carlos Grande, Johnson, Peter W, van Imhoff, Gustaaf W, Ng, Thomas, Dwyer, Karen, Morschhauser, Franck

Get full text

Targeting prohibitins induces apoptosis in acute myeloid leukemia cells by Pomares, Helena, Palmeri, Claudia M, Iglesias-Serret, Daniel, Moncunill-Massaguer, Cristina, Saura-Esteller, José, Núñez-Vázquez, Sonia, Gamundi, Enric, Arnan, Montserrat, Preciado, Sara, Albericio, Fernando, Lavilla, Rodolfo, Pons, Gabriel, González-Barca, Eva M, Cosialls, Ana M, Gil, Joan

“…Fluorizoline is a new synthetic molecule that induces apoptosis by selectively targeting prohibitins (PHBs). In this study, the pro-apoptotic effect of…”
Get full text

Night shift work and chronic lymphocytic leukemia in the MCC‐Spain case–control study by Costas, Laura, Benavente, Yolanda, Olmedo‐Requena, Rocío, Casabonne, Delphine, Robles, Claudia, Gonzalez‐Barca, Eva‐Maria, de la Banda, Esmeralda, Alonso, Esther, Aymerich, Marta, Tardón, Adonina, Marcos‐Gragera, Rafael, Gimeno‐Vázquez, Eva, Gómez‐Acebo, Inés, Papantoniou, Kyriaki, Castaño‐Vinyals, Gemma, Aragonés, Nuria, Pollán, Marina, Kogevinas, Manolis, de Sanjosé, Silvia

“…Chronic lymphocytic leukemia (CLL) has few known modifiable risk factors. Recently, circadian disruption has been proposed as a potential contributor to…”
Get full text

R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study by Martin, Alejandro, Conde, Eulogio, Arnan, Montserrat, Canales, Miguel A, Deben, Guillermo, Sancho, Juan M, Andreu, Rafael, Salar, Antonio, Garcia-Sanchez, Pedro, Vazquez, Lourdes, Nistal, Sara, Requena, Maria-Jose, Donato, Eva M, Gonzalez, Jose A, Leon, Angel, Ruiz, Concepcion, Grande, Carlos, Gonzalez-Barca, Eva, Caballero, Maria-Dolores, on behalf of 'Grupo Espanol de Linfomas/Trasplante Autologo de Medula Osea' (GEL/TAMO cooperative group)

“…1 Complejo Hospitalario de Zamora 2 Hospital Marqués de Valdecilla, Santander 3 Hospital Duran i Reynals, L’Hospitalet de Llobregat 4 Hospital La Paz, Madrid 5…”
Get full text

Rituximab, Fludarabine, Cyclophosphamide, and Mitoxantrone: A New, Highly Active Chemoimmunotherapy Regimen for Chronic Lymphocytic Leukemia by BOSCH, Francesc, ABRISQUETA, Pau, GARCIA MARCO, José Antonio, ESCODA, Lourdes, FERRER, Secundino, MONZO, Encarnación, GONZALEZ, Yolanda, ESTANY, Cristina, JARQUE, Isidro, SALAMERO, Olga, MUNTANOLA, Ana, MONTSERRAT, Emili, VILLAMOR, Neus, TEROL, Maria José, GONZALEZ-BARCA, Eva, FERRA, Christelle, GONZALEZ DIAZ, Marcos, ABELLA, Eugenia, DELGADO, Julio, CARBONELL, Félix

“…The addition of monoclonal antibodies to chemotherapy has significantly improved treatment of chronic lymphocytic leukemia (CLL). Based on excellent results…”
Get full text

Insulin‐like growth factor levels and chronic lymphocytic leukaemia: results from the MCC‐Spain and EpiLymph‐Spain studies by Casabonne, Delphine, Benavente, Yolanda, Costas, Laura, Robles, Claudia, Gonzalez‐Barca, Eva, Banda, Esmeralda, Alonso, Esther, Aymerich, Marta, Campo, Elías, Marcos‐Gragera, Rafael, Tardón, Adonina, Olmedo‐Requena, Rocío, Gimeno, Eva, Martínez‐López, Alba, Casanovas, Oriol, Castaño‐Vinyals, Gemma, Aragonés, Nuria, Pollán, Marina, Kogevinas, Manolis, Sanjosé, Silvia

“…Spanish Ministry of Economy and Competitiveness–CarlosIII Institute of Health cofunded by FEDER funds/European Regional Develpment Fund (ERDF)–a way to build…”
Get full text

Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan plus BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial by Briones, Javier, Novelli, Silvana, García-Marco, José A, Tomás, José F, Bernal, Teresa, Grande, Carlos, Canales, Miguel A, Torres, Antonio, Moraleda, José M, Panizo, Carlos, Jarque, Isidro, Palmero, Francisca, Hernández, Miguel, González-Barca, Eva, López, Dulce, Caballero, Dolores

“…Lymphoma patients with persistent disease undergoing autologous transplantation have a very poor prognosis in the rituximab era. The addition of…”
Get full text

Contribution of cerebrospinal fluid sCD19 levels to the detection of CNS lymphoma and its impact on disease outcome by Muñiz, Carmen, Martín-Martín, Lourdes, López, Antonio, Sánchez-González, Blanca, Salar, Antonio, Almeida, Julia, Sancho, Juan-Manuel, Ribera, José María, Heras, Cecilia, Peñalver, Francisco Javier, Gómez, Marta, González-Barca, Eva, Alonso, Natalia, Navarro, Belén, Olave, Teresa, Sala, Francisco, Conde, Eulogio, Márquez, José Antonio, Cabezudo, Elena, Cladera, Antonia, García-Malo, María, Caballero, María Dolores, Orfao, Alberto

“…Flow cytometry (FCM) is more sensitive than conventional cytology for detection of occult leptomeningeal lymphoma; however, some FCM-negative patients show…”
Get full text

Testicular large B‐cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL by Rivas‐Delgado, Alfredo, López, Cristina, Clot, Guillem, Nadeu, Ferran, Grau, Marta, Frigola, Gerard, Bosch‐Schips, Jan, Radke, Josefine, Ishaque, Naveed, Alcoceba, Miguel, Tapia, Gustavo, Luizaga, Luis, Barcena, Carmen, Kelleher, Nicholas, Villamor, Neus, Baumann, Tycho, Muntañola, Ana, Sancho‐Cia, Juan M., García‐Sancho, Alejandro M., Gonzalez‐Barca, Eva, Matutes, Estella, Brito, Jordi A., Karube, Kennosuke, Salaverria, Itziar, Enjuanes, Anna, Wiemann, Stefan, Heppner, Frank L., Siebert, Reiner, Climent, Fina, Campo, Elías, Giné, Eva, López‐Guillermo, Armando, Beà, Silvia

“…Testicular large B‐cell lymphoma (TLBCL) is an infrequent and aggressive lymphoma arising in an immune‐privileged site and has recently been recognized as a…”
Get full text